Editor's Note The spread of COVID-19 in the US could result in hundreds of billions of dollars in direct medical costs, according to this study partially funded by the Agency for Healthcare Research and Quality (AHRQ). Using AHRQ data and other sources, researchers developed computer models to simulate the financial…
Editor's Note The Occupational Safety and Health Administration (OSHA) on April 24 issued interim guidance on the reuse and decontamination of N95 and other filtering-facepiece respirators during the COVID-19 pandemic. OSHA notes that the National Institute for Occupational Safety and Health (NIOSH) has identified research that suggests the following methods…
Editor's Note In this study from BJC HealthCare and Washington University School of Medicine, St Louis, a multidisciplinary team that included surgeons created a new process for disinfecting and reusing N95 masks, using vaporized hydrogen peroxide. The process allows healthcare workers (HCW) to reuse masks up to 20 cycles, and…
Editor's Note An artificial intelligence (AI) tool that analyzes CT scans of the chest was 75% accurate in determining COVID-19 patients who required ventilators, the April Radiology Business reports. Researchers at Cleveland’s Case Western Reserve University built the tool using scans and datasets from the web, COVID-19 chest images from…
Editor's Note: A research team led by the University of Singapore has developed an artificial intelligence (AI) platform called, “IDentif.AI” (Indentifying Infectious Disease Combination Therapy with Artificial Intelligence) to increase efficiency in the development of treatments that combine several different drugs. The researchers selected 12 drugs that are viable candidates…
Editor's Note: Epic’s deterioration index, an artificial intelligence (AI), machine learning-based system that can predict which patients with COVID-19 could become seriously ill, has been put into use at hospitals nationwide, the April 24 STAT reports. Though normally hospitals would take weeks or months to test a new tool on…
Editor's Note COVID-19 may predispose patients to venous and arterial thrombotic disease because of excessive inflammation, platelet activation, endothelial dysfunction, and stasis, this study finds. Though a recent document from the Centers for Disease Control and Prevention indicates an increased risk of severe COVID-19 in patients receiving antiplatelet agents and…
Editor's Note The Joint Commission on April 23 announced that it supports the Centers for Disease Control and Prevention’s new recommendations that healthcare facilities “. . . implement source control for everyone entering a healthcare facility (eg, healthcare personnel, patients, visitors), regardless of symptoms . . .” Source control involves…
Editor's Note Alterations in smell or taste were frequently reported in mildly symptomatic patients with COVID-19 infection and often were the first apparent symptom, this study finds. In this telephone survey of 202 COVID-19 outpatients, 130 (64.4%) reported an altered sense of smell or taste. Of these, 45 (34.6%) also…
Editor's Note Israel-based Scentech Medical and Meir Medical Center will start a trial of Scentech’s breath technology, which is designed to detect COVID-19 before it becomes symptomatic, the April 22 Times of Israel reports. The breath test technology—similar to breathalyzers used on suspected drunk drivers—is a mix of software and…